Merck & Co. (MRK)
(Delayed Data from NYSE)
$104.40 USD
-1.14 (-1.08%)
Updated Mar 22, 2023 04:03 PM ET
After-Market: $104.44 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
MRK 104.40 -1.14(-1.08%)
Will MRK be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRK
Here's Why You Should Add Novo (NVO) Stock to Your Portfolio
The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
Top Research Reports for Merck, Intel & MercadoLibre
Merck (MRK) Stock Up 31.6% in a Year: What Awaits in 2023?
Other News for MRK
No Record found.